PainChek®, developer of the world’s first smartphone-based pain assessment and monitoring application, has been granted a patent in 20 European nations by the European Patent Office.
The Sydney-based medical technology company said that its patent application, entitled “A Pain Assessment Method and System”, enables PainChek to safeguard the intellectual property of its pain assessment and monitoring technology within the European market.
Countries covered by the patent include: Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Slovenia, Spain, Sweden, Switzerland and the United Kingdom. The patent protection for all these regions is until 2035.
Paincheck said the patent further strengthens PainChek’s global intellectual property portfolio, which includes existing patents in the USA, Japan, and China.
Philip Daffas, CEO of PainChek, commented: “The granting of this European patent is a pivotal achievement for PainChek as it solidifies our position in one of the world’s largest healthcare markets, including the UK which is a particularly important growth region for the company.
“This protection enhances our ability to deliver innovative pain assessment solutions to a broader audience, ensuring better pain assessment and management for individuals in need.”
Paincheck opened flat this morning and was trading at 31 cents.